Article Public (all visitors)

FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News

Berkeley News 2021

UC scientists and physicians hope to permanently cure patients of sickle cell disease by using CRISPR-Cas9 to replace a defective gene with the normal version

View Original Source

Curated by

FoundryBase

Updated 11 months ago

BIOLOGY   BIOTECH   GENETICS   HEALTHCARE  

Save

Bookmark this resource

Browse more

View all Articles

Placed in

Chunks with this Article

1 chunk • used in 1 course

CRISPR, gene editing and DNA manipulation - examples, use cases A collection of resources about CRISPR, gene editing, and DNA manipulation, featuring detailed examples and use cases. Key themes include... FoundryBase 13 resources

Learning paths and sections

Used in 1 learning path.

Adjacent discoveries

Related resources

Shared chunks

Resources placed near this one.

Shared categories

Resources with similar topic signals.

Continue from source

More from source

Browse more from Berkeley News

Contribute to FoundryBase

Found something worth adding?

Sign in to suggest resources and start building your own collection.

Log in to suggest Create account